243 related articles for article (PubMed ID: 29222311)
21. The tumour microenvironment in B cell lymphomas.
Scott DW; Gascoyne RD
Nat Rev Cancer; 2014 Aug; 14(8):517-34. PubMed ID: 25008267
[TBL] [Abstract][Full Text] [Related]
22. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis.
Gallouet AS; Travert M; Bresson-Bepoldin L; Guilloton F; Pangault C; Caulet-Maugendre S; Lamy T; Tarte K; Guillaudeux T
Clin Cancer Res; 2014 May; 20(10):2663-73. PubMed ID: 24637636
[TBL] [Abstract][Full Text] [Related]
23. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
[TBL] [Abstract][Full Text] [Related]
24. Cellular composition of the tumor microenvironment.
Ansell SM; Vonderheide RH
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714465
[TBL] [Abstract][Full Text] [Related]
25. Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance.
Aldinucci D; Celegato M; Casagrande N
Cancer Lett; 2016 Sep; 380(1):243-52. PubMed ID: 26474544
[TBL] [Abstract][Full Text] [Related]
26. The role of T cells in the microenvironment of Hodgkin lymphoma.
Wein F; Küppers R
J Leukoc Biol; 2016 Jan; 99(1):45-50. PubMed ID: 26320264
[TBL] [Abstract][Full Text] [Related]
27. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities.
Liu Y; Zhou X; Wang X
J Hematol Oncol; 2021 Aug; 14(1):125. PubMed ID: 34404434
[TBL] [Abstract][Full Text] [Related]
28. Stromal cell contribution to human follicular lymphoma pathogenesis.
Mourcin F; Pangault C; Amin-Ali R; Amé-Thomas P; Tarte K
Front Immunol; 2012; 3():280. PubMed ID: 22973275
[TBL] [Abstract][Full Text] [Related]
29. CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.
Dürr C; Pfeifer D; Claus R; Schmitt-Graeff A; Gerlach UV; Graeser R; Krüger S; Gerbitz A; Negrin RS; Finke J; Zeiser R
Cancer Res; 2010 Dec; 70(24):10170-81. PubMed ID: 21159639
[TBL] [Abstract][Full Text] [Related]
30. Tuning cancer fate: the unremitting role of host immunity.
Calì B; Molon B; Viola A
Open Biol; 2017 Apr; 7(4):. PubMed ID: 28404796
[TBL] [Abstract][Full Text] [Related]
31. The microenvironment in lymphomas--dissecting the complex crosstalk between tumor cells and 'by-stander' cells.
Rosenquist R; Davi F; Ghia P
Semin Cancer Biol; 2014 Feb; 24():1-2. PubMed ID: 24365642
[TBL] [Abstract][Full Text] [Related]
32. Cell communication and signaling: how to turn bad language into positive one.
Chiodoni C; Di Martino MT; Zazzeroni F; Caraglia M; Donadelli M; Meschini S; Leonetti C; Scotlandi K
J Exp Clin Cancer Res; 2019 Mar; 38(1):128. PubMed ID: 30867009
[TBL] [Abstract][Full Text] [Related]
33. Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs.
Höpken UE; Rehm A
J Mol Med (Berl); 2012 Nov; 90(11):1237-45. PubMed ID: 22577036
[TBL] [Abstract][Full Text] [Related]
34. Lymphoma Microenvironment and Immunotherapy.
Xu ML; Fedoriw Y
Surg Pathol Clin; 2016 Mar; 9(1):93-100. PubMed ID: 26940270
[TBL] [Abstract][Full Text] [Related]
35. CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non-Hodgkin lymphoma.
Dakappagari N; Ho SN; Gascoyne RD; Ranuio J; Weng AP; Tangri S
Cytometry B Clin Cytom; 2012 Mar; 82(2):112-9. PubMed ID: 22076940
[TBL] [Abstract][Full Text] [Related]
36. B cell/stromal cell crosstalk in health, disease, and treatment: Follicular lymphoma as a paradigm.
Lamaison C; Tarte K
Immunol Rev; 2021 Jul; 302(1):273-285. PubMed ID: 34060097
[TBL] [Abstract][Full Text] [Related]
37. Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.
Carbone A; Gloghini A; Castagna L; Santoro A; Carlo-Stella C
J Pathol; 2015 Sep; 237(1):4-13. PubMed ID: 25953622
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of B-cell lymphoma pathogenesis.
Küppers R
Nat Rev Cancer; 2005 Apr; 5(4):251-62. PubMed ID: 15803153
[TBL] [Abstract][Full Text] [Related]
39. The chronic lymphocytic leukemia microenvironment: Beyond the B-cell receptor.
Choi MY; Kashyap MK; Kumar D
Best Pract Res Clin Haematol; 2016 Mar; 29(1):40-53. PubMed ID: 27742071
[TBL] [Abstract][Full Text] [Related]
40. CCL7 Signaling in the Tumor Microenvironment.
Lee YS; Cho YB
Adv Exp Med Biol; 2020; 1231():33-43. PubMed ID: 32060844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
